Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States

Lung Cancer

Volumn 15, Issue 1, 1996, Pages 1-20

  Kabat, Geoffrey C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Difference between blacks and whites; Endocrine factors; Environmental Tobacco Smoke (ETS); Lung cancer; Mentholated cigarettes; Previous cancer; Radiotherapy; Risk factors other than smoking; Smokers and nonsmokers

Indexed keywords

TOBACCO SMOKE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; UNITED STATES;

EID: 0030220920     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(95)00566-8     Document Type: Review

References (55)

1. [1] Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45: 8-30.
2. [2] Parkin DM. Trends in lung cancer incidence worldwide. Chest 1989; 96: 5S-8S.
3. [3] Devesa SS, Shaw GL, Blot WJ. Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prev 1991; 1: 29-34.
4. [4] Rabat GC, Wynder EL. Lung cancer in nonsmokers. Cancer 1984; 53: 1214-1221.
5. [5] Fontham ET, Correa P, Reynolds P, et al. Environmental tobacco smoke and lung cancer in nonsmoking women: a multicenter study. J Am Med Assoc 1994; 271: 1752-1759.
6. [6] Axelson O, Davis DL, Forestiere F, et al. Lung cancer not attributable to smoking. Ann New York Acad Sci 1990; 609: 165-178.
7. [7] Kabat GC. Recent developments in the epidemiology of lung cancer. Semin Surg Oncol 1993; 9: 73-79.
8. [8] Wynder EL, Kabat GC. The effect of low-yield cigarette smoking on lung cancer risk. Cancer 1988; 62: 1223-1230.
9. [9] Kabat GC, Hebert RJ. Use of mentholated cigarettes and lung cancer risk. Cancer Res 1991; 51: 6510-6513.
10. [10] Kabat GC, Morabia A, Wynder EL. Comparison of smoking habits of blacks and whites in a case-control study. Am J Public Health 1991; 81: 1483-1486.
11. [11] Kabat GC, Stellman SD, Wynder EL. Relation between environmental tobacco smoke and lung cancer in lifetime nonsmokers. Am J Epidemiol 1995; 142: 141-148.
12. [12] Kabat GC. Previous cancer and radiotherapy as risk factors for lung cancer in lifetime nonsmokers. Cancer Causes Control 1993; 4: 489-495.
13. [13] Kabat GC, Wynder EL. Body mass index and lung cancer risk. Am J Epidemiol 1992; 135: 769-774.
14. [14] Kreyberg L. Histological lung cancer types. A morphological and biological correlation. Acta Pathol Microbiol Scand Suppl 1962; 157: 1-92.
15. [15] Weiss W, Boucot KR, Seidman H, et al. Risk of lung cancer according to histologic type and dosage. J Am Med Assoc 1972; 222: 799-801.
16. [16] Lubin JH, Blot WJ. Assessment of lung cancer risk factors by histologic category. J Natl Cancer Inst 1984; 73: 383-389.
17. [17] Damber LA, Larsson LG. Smoking and lung cancer with special regard to type of smoking and type of cancer. A case-control study in north Sweden. Br J Cancer 1986; 53: 673-681.
18. [18] Morabia A, Wynder EL. Cigarette smoking and lung cancer cell types. Cancer 1991; 68: 2074-2078.
19. [19] Brownson RC, Chang JC, Davis JR. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology 1992; 3: 61-64.
20. [20] Gao YT, Blot WJ, Zheng W, Fraumeni JF, Hsu CW. Lung cancer and smoking in Shanghai. Int J Epidemiol 1988; 17: 277-280.
21. [21] McDuffie HH, Klaassen DJ, Dosman JA. Determinants of cell type in patients with cancer of the lungs. Chest 1990; 98: 1187-1193.
22. [22] Yang CP, Gallagher RP, Weiss NS, et al. Differences in incidence rates of cancers of the respiratory tract by anatomic subsite and histologic type: an etiologic implication. J Natl Cancer Inst 1989; 81: 1828-1831.
23. [23] Ries LAG, Hankey BF, Edwards BK. Cancer statistics review, 1973-1988. NIH Publ. No. 91-2789, National Cancer Institute, 1991.
24. [24] Sidney S, Tekawa I, Friedman GD. Mentholated cigarette use among multiphasic examinees, 1979-86. Am J Public Health 1989; 79: 1415-1416.
25. [25] National Cancer Institute. Bioassays of DL-menthol for possible carcinogenicity. Natl Cancer Inst. Carcinogenesis Tech Repl Ser 1979; 98: 1-123.
26. 14C-menthol. Beitr Tabakforsch Int 1970; 5: 299-301.
27. [27] Wagenknekt LE, Cutter GR, Haley NJ, et al. Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults Study. Am J Public Health 1990; 80: 1053-1056.
28. [28] Hebert JR. Differences in biological responses to cigarette smoking remain unexplained (Letter). Am J Public Health 1991; 81: 1679-1680.
29. [29] Stellman SD. Interactions between smoking and other exposures: occupation and diet. Banbury Rept 23: Mechanisms in tobacco carcinogenesis. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986; 377-395.
30. [30] Caporaso NE, Tucker MA, Hoover RN, et al. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 1990; 82: 1264-1272.
31. [31] Weston A, Vineis P, Caporaso NE, Krontiris TG, Lonergan JA, Sugimura H. Racial variation in the distribution of Ha-ras 1 alleles. Mol Carcinog 1991; 4: 265-268.
32. [32] Wynder EL, Goodman MT. Smoking and lung cancer: some unresolved issues. Epidemiol Rev 1983; 5: 177-207.
33. [33] U.S. Environmental Protection Agency. Respiratory health effects of passive smoking: lung cancer and other disorders. (EPA/600/6-90/006F). Washington, DC: US EPA, Office of Research and Development RD-689, 1992.
34. [34] National Research Council. Environmental tobacco smoke: measuring exposures and assessing health effects. Washington, DC: National Academy Press, 1986.
35. [35] Kohn HI, Fry RJM. Radiation carcinogenesis. New Engl J Med 1984; 310: 504-511.
36. [36] National Research Council, Committee on the Biological Effects of Ionizing Radiation. The effects on populations of exposure to low levels of ionizing radiation. Washington, DC: National Academy of Sciences, 1980.
37. [37] Court Brown WM, Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 1965; 2: 1327-1332.
38. [38] Neugut AI, Robinson E, Lee WC, et al. Lung cancer after radiation therapy for breast cancer. Cancer 1993; 71: 3054-3057.
39. [39] Harvey EB, Brinton LA. Second cancer following cancers of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985; 68: 99-112
40. [40] Curtis RE, Hoover RN, Kleinerman RA, et al. Second cancer following cancer of the female genital system in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985; 68: 113-137.
41. [41] Ewertz M, Mouridsen HT. Second cancer following cancers of the female breast in Denmark, 1943-80. Natl Cancer Inst Monogr 1985; 68: 325-329.
42. [42] Annegers JF, Malkasian GD. Patterns of other neoplasia in patients with endometrial carcinoma. Cancer 1981; 48: 856-859.
43. [43] Chaudhuri PK, Thomas PN, Walker MJ, et al. Steroid receptors in human lung cancer cytosols. Cancer Lett 1982; 16: 327-332.
44. [44] Kobayashi S, Mizuno T, Tobioka N, et al. Sex steroid receptors in diverse human tumors. Gann 1982; 23: 439-445.
45. [45] Beattie CW, Hansen NW, Thomas PA. Sex steroid receptors in human lung cancer. Cancer Res 1985; 45: 4206-4214.
46. [46] Cagle PT, Mody DR, Schwartz MR, Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res 1990; 150: 6632-6635.
47. [47] Gao Y-T, Blot WJ, Zheng W, et al. Lung cancer among Chinese women. Int J Cancer 1987; 40: 604-609.
48. [48] Adami H-O, Persson I, Hoover R, et al. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44: 833-839.
49. [49] Taioli E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994; 86: 869-870.
50. [50] Sellers TA, Potter JD, Folsom AR. Association of incident lung cancer with family history of female reproductive cancers: the Iowa Women's Health Study. Genet Epidemiol 1991; 8: 199-208.
51. [51] Wu AH, Yu MC, Thomas DC, et al. Personal and family history of lung disease as risk factors for adenocarcinoma. Cancer Res 1988; 48: 7279-7284.
52. [52] Kabat GC, Chang CJ, Wynder EL. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 1994; 23: 1137-1144.
53. [53] Knekt P, Heliovaara M, Riisanen A, et al. Leanness and lung cancer. Int J Cancer 1991; 49: 208-213.
54. [54] Kark JD, Yaari S, Rasooly I, Goldbourt U. Are lean smokers at increased risk of lung cancer? The Israeli Civil Servant Cancer Study. Arch Int Med 1995; 155: 2409-2416.
55. [55] Grinberg-Funes RA, Singh VN, Perera FP, et al. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype. Carcinogenesis 1994; 15: 2449-2454.